trimetazidine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, C; Li, X; Liu, X; Lu, S; Wu, C; Zhang, Y; Zhou, H | 1 |
1 other study(ies) available for trimetazidine and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway.
Topics: AMP-Activated Protein Kinases; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Body Weight; Diet, High-Fat; Disease Models, Animal; Forkhead Box Protein O1; Gene Expression Regulation; Hep G2 Cells; Humans; Lipogenesis; Male; Mice; Non-alcoholic Fatty Liver Disease; Palmitates; Signal Transduction; Trimetazidine | 2020 |